GB-5267

N/A

Report date: 2026/03/26 20:00:17

Base Information

Drug NameGB-5267

Drug Alias NameIL-18 Armored CAR T Cell Product Targeting MUC16 therapy (Generate Biomedicines)GB-5267

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionT lymphocyte replacementsMucin-16 modulators

TargetsMucin-16

Therapy Area/IndicationsOvarian Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesGenerate Biomedicines Inc

China Registration ClassN/A

Develop Information

Active CompaniesGenerate Biomedicines Inc Roswell Park Cancer Institute

Inactive CompaniesN/A

Active IndicationsOvarian Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A